For the Inventor, By the Inventor

Enter assignee name

Santen Sas

USPTO Granted Patents = 15

CIPO Patents = 4

EPO Patents = 9

Trademarks = 3

Forward Citations = 12

Loading Chart...

Loading Chart...

15 inventors (with patents filed for the assignee):

Frederic Lallemand (10 out of 14 patents)

Gregory Lambert (8 out of 23 patents)

Betty Philips (8 out of 16 patents)

4. Laura Rabinovich-Guilatt (7 out of 14 patents)

5. Jean-Sébastien Garrigue (4 out of 7 patents)

6. Frédéric Lallemand (3 out of 4 patents)

7. Jean-Sebastien Garrigue (3 out of 3 patents)

8. Philippe Daull (3 out of 3 patents)

9. Christophe Baudouin (2 out of 4 patents)

10. Jeffrey Heier (1 out of 1 patent)

11. Pascal Candillon (1 out of 1 patent)

12. Julien Lafosse (1 out of 1 patent)

13. Betty Phillips (1 out of 1 patent)

14. Laura Rabinovich (1 out of 1 patent)

15. Jennifer Dourlat (1 out of 1 patent)

15 patents: Sort by Forward Citations

1. 11612658 - Oil-in-water emulsions comprising cetalkonium chloride and methods of making and using the same (2023-03-28),

2. 11452739 - Polysaccharides for the treatment of ocular conditions (2022-09-27),

3. 10842873 - Methods for preparing oil-in-water emulsions comprising cetalkonium chloride (2020-11-24),

4. 9956289 - Emulsion compositions containing quaternary ammonium compounds (2018-05-01),

5. 9682147 - Self-preserved oil dispersions comprising boric acid (2017-06-20),

6. 9616016 - Method for treating retinal conditions using an intraocular tamponade (2017-04-11),

7. 9555045 - Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions (2017-01-31),

8. 9364461 - Process for manufacturing ophthalmic oil-in-water emulsions (2016-06-14),

9. 9220694 - Emulsion compositions containing cetalkonium chloride (2015-12-29),

10. 9192567 - Method for treating eye disease or conditions affecting the posterior segment of the eye (2015-11-24),

11. 9132071 - Compositions containing quaternary ammonium compounds (2015-09-15),

12. 9107822 - Water-in oil type emulsion for treating a disease of the eye (2015-08-18),

13. 9089480 - Anionic oil-in-water emulsions containing prostaglandins and uses thereof (2015-07-28),

14. 9072750 - Use of prostaglandins F2Alpha and analogues for the healing of corneal and conjunctival lesions (2015-07-07),

15. 8623852 - Topical methods and compositions for the treatment of eye diseases and conditions (2014-01-07),

SANTEN SAS is a leading global pharmaceutical company specializing in ophthalmology. With a strong commitment to fulfilling unmet medical needs, the company develops innovative solutions to improve eye health and enhance vision. Santen offers a wide range of products, including prescription pharmaceuticals, over-the-counter drugs, and medical devices, catering to various eye conditions. With a dedicated team of scientists, researchers, and healthcare professionals, Santen strives to provide better vision and improved quality of life for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 20 2026

15 Patents

#6 in Evry

#1,228 in France

#38,803 in the World

Santen Sas

Forward Citations = 12

15 inventors:

Frederic Lallemand (10 out of 14 patents)

Gregory Lambert (8 out of 23 patents)

Betty Philips (8 out of 16 patents)

4. Laura Rabinovich-Guilatt (7 out of 14 patents)

5. Jean-Sébastien Garrigue (4 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…